RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Accelerated Approval, surrogate endpoints, registration Additionally, and as importantly, ONCY's oncolytic virus pelareorep is administered through intravenous (IV) injection rather than intratumoral (IT) injection, which is the route most other oncolytic viruses are administered. Consequently ONCY's pelareorep has few OV competitors since IV administration is the route that Big Pharma wants. And not IT.